Profile cover photo
Profile photo
Hadasit Bio-Holdings Ltd.
A publicly traded subsidiary (OTCBB: HADSY) of the Hadassah University Hospital.
A publicly traded subsidiary (OTCBB: HADSY) of the Hadassah University Hospital.

Hadasit Bio-Holdings Ltd.'s posts

Post has attachment
Did you miss our webinar that took place on February 7th? Watch the replay to find out what CEO Ophir Shahaf had to say 

Post has attachment
Mr. Shahaf will discuss Hadasit’s special relationship with the Hadassah hospitals, its unique business model and the amazing science behind each portfolio company. After his discussion, attendees are encouraged to participate in the Q&A session.

Register now:

Post has attachment
Hadasit Bio-Holdings is pleased to announce that on Thursday February 7, 2013 at 2pm EST we will be hosting a webinar featuring CEO Ophir Shahaf. Register and find out more information about the webinar at

Hadasit's Q3 report shows capital gain of 7M NIS. Ophir Shahaf, CEO of Hadasit-Bio says he "expects that this trend will continue and we will continue to bring our companies closer to an exit.” Get the full details at 

Did you know Ischemic stroke is the leading cause of adult disability in the United States and Europe? This is why Thrombotech is developing a drug to improve the safety of stroke treatments. Learn more at 

HadasitBio CEO Ophir Shahaf explains what the market looks like for HadasitBio’s 6 portfolio companies at

Hadasit Bio CEO Ophir Shahaf is interviewed by Globes about the Company’s move away from pharmaceutical sales and toward investments. More about the transformation at  

What is the forecast for the global market of breast cancer diagnostic and drug technologies? Find out at

How does HadasitBio plan on moving forward with their portfolio companies? CEO Ophir Shahaf shares the latest news at

How is Hadassah University Medical Center building a better future for all? Find out more about their medical breakthroughs at
Wait while more posts are being loaded